Mesalamine: Clinical Trials

20 trials of Mesalamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 1 active not recruiting, 1 terminated, 1 unknown. 20 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 120Completed 17, Active not recruiting 1, Terminated 1, Unknown 1
Phase 24Completed 2, Active not recruiting 1, Unknown 1

Follow Mesalamine: new trials by email Literature Review of Mesalamine trials Research Report on Mesalamine

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder)
Phase 1 / Phase 2Active not recruitingIcahn School of Medicine at Mount Sinai32022-06-102025-02-11
Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
Apriso 0.375G ER CAP, APRISO 375 mg extended-release capsules - Ulcerative Colitis
Phase 1CompletedBausch Health Americas, Inc.602017-05-152018-05-08
Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation
Phase 1 / Phase 2UnknownResearch Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan3002015-01-012023-03-03
Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers
IBD98-M:, IBD98-M without HA, Delzicol - Healthy
Phase 1CompletedHoly Stone Healthcare Co., Ltd302014-07-012015-04-22
Taste Assessment Study of SHP429 in Healthy Adult Subjects
Mesalamine - Healthy
Phase 1CompletedShire182014-06-022021-06-03
TP0502-B-Pharmaco-Scintigraphic-Study
TP05 - Ulcerative Colitis
Phase 1CompletedTillotts Pharma AG92013-09-012014-12-04
Mesalamine in Environmental Enteropathy
Mesalamine, Placebo granules - Malnutrition
Phase 1 / Phase 2CompletedKelsey Jones442013-06-012014-07-11
TP0502-Pharmaco-Scintigraphic-Study and Amendment
TP05 Coating D, TP05 Coating E, TP05 Coating H - Ulcerative Colitis
Phase 1CompletedTillotts Pharma AG262012-10-012014-12-03
TP0501 - Pharmaco-Scintigraphic-Study
TP05 Coating A, TP05 Coating B - Ulcerative Colitis
Phase 1CompletedTillotts Pharma AG182011-12-012014-12-03
Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine
sulfamethoxazole + MMX placebo, Sulfamethoxazole + MMX Mesalazine/mesalamine - Healthy
Phase 1CompletedShire442011-11-072021-07-13
Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine
Amoxicillin + MMX placebo, Amoxicillin + MMX mesalazine/mesalamine - Healthy
Phase 1CompletedShire622011-10-072021-06-09
Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine
Metronidazole + MMX Mesalazine/mesalamine placebo, Metronidazole + MMX Mesalazine/mesalamine - Healthy
Phase 1CompletedShire302011-08-222021-06-09
Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
Ciprofloxacin XR + MMX Placebo, MMX Mesalazine/mesalamine + Ciprofloxacin XR - Healthy
Phase 1CompletedShire302011-07-252021-06-09
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
MMX Mesalamine - Ulcerative Colitis
Phase 1CompletedShire522010-10-082021-06-14
Targeting Oxidative Stress in Chronic Beryllium Disease
Mesalamine, Placebo - Chronic Beryllium Disease
Phase 1 / Phase 2CompletedNational Jewish Health182010-03-012018-10-12
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
mesalamine, ALTH12-1:4, ALTH12-2:4 - Ulcerative Colitis
Phase 1CompletedAltheus Therapeutics, Inc.92009-11-012011-03-29
PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
mesalamine - Healthy
Phase 1CompletedBausch Health Americas, Inc.242008-02-012019-11-18
Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
Asacol, Lialda - Healthy
Phase 1CompletedWarner Chilcott372007-03-012013-04-17
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
mesalamine - Ulcerative Colitis
Phase 1TerminatedWarner Chilcott342005-10-012013-04-17
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients
5-aminosalicylic acid - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)141999-10-012007-05-25

Conditions studied

Colitis, Ulcerative (9)  ·  Inflammatory Bowel Diseases (2)  ·  Berylliosis (1)  ·  Colitis (1)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  HIV Infections (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Mucositis (1)  ·  Protozoan Infections (1)  ·  Trematode Infections (1)

Sponsors

Shire (6)  ·  Tillotts Pharma AG (3)  ·  Bausch Health Americas, Inc. (2)  ·  Warner Chilcott (2)  ·  Altheus Therapeutics, Inc. (1)  ·  Holy Stone Healthcare Co., Ltd (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kelsey Jones (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Jewish Health (1)  ·  Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1)

Countries

United States (14)  ·  Australia (1)  ·  Canada (1)  ·  Kenya (1)  ·  Poland (1)  ·  Slovakia (1)  ·  United Kingdom (1)

Top investigators

Audrey Shaw, PhD (1)  ·  Brian Day, PhD (1)  ·  Denis Audet, M.D. (1)  ·  Judy H Cho, MD (1)  ·  Kelsey DJ Jones, MBBS BA MRCPCH (1)  ·  Lisa A. Maier, M.D., MSPH (1)  ·  Peter A. Anton, MD (1)  ·  Philip B Miner, M.D. (1)  ·  Subra Kugathasan, MD (1)  ·  William Aronstein, MD, PhD (1)  ·  William S Aronstein, MD, PhD (1)

Results publications

PMID 24868146, PMID 25189855, PMID 26893546, PMID 32671846, PMID 33188747

NIH funding

K24AI001610 (1)